Extracellular volume quantification by cardiac magnetic resonance imaging without hematocrit sampling: ready for prime time?

AA Kammerlander, F Duca, C Binder… - Wiener klinische …, 2018 - Springer
Background Myocardial tissue characterization by cardiovascular magnetic resonance
(CMR) T1 mapping currently receives increasing interest as a diagnostic tool in various …

Right and left ventricle native T1 mapping in systolic phase in patients with congenital heart disease

F Secchi, M Alì, CB Monti, A Greiser… - Acta …, 2021 - journals.sagepub.com
Background T1 mapping is emerging as a powerful tool in cardiac magnetic resonance
(CMR) to evaluate diffuse fibrosis. However, right ventricular (RV) T1 mapping proves …

Long-standing cyanosis in congenital heart disease does not cause diffuse myocardial fibrosis

A Kharabish, C Meierhofer, M Hadamitzky, J Nadjiri… - Pediatric …, 2018 - Springer
The assumption of the presence of diffuse myocardial fibrosis in long-standing cyanotic
congenital heart disease (CHD) inspired us to noninvasively determine the myocardial …

Dose correction for post-contrast T1 mapping of the heart: the MESA study

ND Gai, V Sandfort, S Liu, JAC Lima… - The international journal …, 2016 - Springer
Post-contrast myocardial T1 (T1 myo, c) values have been shown to be sensitive to
myocardial fibrosis. Recent studies have shown differences in results obtained from T1 myo …

[HTML][HTML] The effect of changes to MOLLI scheme on T1 mapping and extra cellular volume calculation in healthy volunteers with 3 tesla cardiovascular magnetic …

AK McDiarmid, DA Broadbent, DM Higgins… - … imaging in medicine …, 2015 - ncbi.nlm.nih.gov
Background Diffuse myocardial fibrosis may be quantified with magnetic resonance (MR) by
calculating extracellular volume (ECV) fraction from native and post-contrast T1 values. The …

[HTML][HTML] Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the …

JC Moon, DR Messroghli, P Kellman… - Journal of …, 2013 - Elsevier
Rapid innovations in cardiovascular magnetic resonance (CMR) now permit the routine
acquisition of quantitative measures of myocardial and blood T1 which are key tissue …

CMR–derived extracellular volume fraction as a marker for myocardial fibrosis: the importance of coexisting myocardial inflammation

JA Lurz, C Luecke, D Lang, C Besler… - JACC: Cardiovascular …, 2018 - jacc.org
Objectives: The aim of the present study was to evaluate whether extracellular volume
fraction (ECV) can reliably inform on the extent of diffuse fibrosis in the simultaneous …

[HTML][HTML] T1 and extracellular volume mapping in the heart: estimation of error maps and the influence of noise on precision

P Kellman, AE Arai, H Xue - Journal of Cardiovascular Magnetic …, 2013 - Elsevier
Background Quantitative measurements in the myocardium may be used to detect both focal
and diffuse disease processes that result in an elevation of T1 and/or extracellular volume …

[HTML][HTML] Can a MR imaging scanner accurately measure hematocrit to determine ECV fraction?

DA Bluemke, N Kawel-Boehm - JACC: Cardiovascular Imaging, 2016 - jacc.org
Focal fibrosis, most due to myocardial infarction, is readily identified by cardiac magnetic
resonance (CMR) using widely validated late gadolinium enhancement methods. However …

T1 mapping by CMR imaging: from histological validation to clinical implication

AA Kammerlander, BA Marzluf, C Zotter-Tufaro… - JACC: Cardiovascular …, 2016 - jacc.org
Objectives: The purpose of this study was to prospectively investigate the diagnostic and
prognostic impact of cardiac magnetic resonance (CMR) T1 mapping and validate it against …